Lifecore Biomedical, Inc. De (LFCR) Gross Profit (2010 - 2025)

Lifecore Biomedical's Gross Profit history runs 16 years deep, the most recent figure standing at $14.0 million for Q2 2025.

• In Q2 2025, Gross Profit fell 19.05% year-over-year to $14.0 million; the TTM figure through May 2025 stood at $40.3 million (down 3.71% YoY), while the FY2025 annual figure was $40.3 million, down 3.71% from the prior year.
• Gross Profit was $14.0 million for Q2 2025 at Lifecore Biomedical, up from $9.8 million in the prior quarter.
• In the past five years, Gross Profit ranged from a high of $17.3 million in Q2 2024 to a low of $2.7 million in Q3 2023.
• Historically, Gross Profit has averaged $9.7 million across 5 years, with a median of $10.2 million in 2022.
• The sharpest annual moves came in 2023 and 2024: Gross Profit sank 54.37% in 2023, then jumped 122.03% in 2024.
• A 5-year view of Gross Profit shows it stood at $11.5 million in 2021, then tumbled by 50.44% to $5.7 million in 2022, then surged by 75.33% to $10.0 million in 2023, then increased by 11.32% to $11.1 million in 2024, then grew by 26.15% to $14.0 million in 2025.
• The last three Gross Profit figures came in at $14.0 million (Q2 2025), $9.8 million (Q1 2025), and $11.1 million (Q4 2024), per Business Quant data.